A Director at Prophase Labs (PRPH) is Buying Shares


Today, a Director at Prophase Labs (PRPH), Jason Michael Barr, bought shares of PRPH for $17.43K.

Following this transaction Jason Michael Barr’s holding in the company was increased by 162.8% to a total of $33.42K.

See today’s analyst top recommended stocks >>

The company has a one-year high of $3.71 and a one-year low of $1.97.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts